Inicio › Linfoma no Hodgkin › Oregón › Portland
Ensayos clínicos de Linfoma no Hodgkin en Portland, OR
15 estudios para Linfoma no Hodgkin buscan participantes en centros de Portland y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
ReclutandoFase 1/2
- Oregon Health and Sciences University, Portland
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
ReclutandoFase 2
- Providence Health & Services, Portland
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
ReclutandoFase 1
- Oregon Health & Science University (OHSU), Portland
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
ReclutandoFase 2
- Research Site, Portland
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
ReclutandoFase 2
- Providence Portland Medical Center, Portland
- Providence St. Vincent Medical Center, Portland
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
ReclutandoFase 1/2
- Oregon Health & Science University, Portland
Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
ReclutandoEstudio observacional
- Oregon Health and Science University Knight Cancer Institute, Portland
DALY II USA/ MB-CART2019.1 for DLBCL
ReclutandoFase 2
- Oregon Health and Science University Knight Cancer Institute, Portland
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
ReclutandoEstudio observacional
- Oregon Health & Science University/Doernbecher Children's Hospital, Portland
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
ReclutandoFase 1/2
- Providence Neurological Specialties West, Portland
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
ReclutandoEstudio observacional
- Kaiser Permanente Northwest, Portland
Study of SGR-1505 in Mature B-Cell Neoplasms
ReclutandoFase 1
- Oregon Health and Science University - Knight Cancer Institute, Portland
Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
ReclutandoEstudio observacional
- Local Institution - 0016, Portland
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutandoEstudio observacional
- Massive Bio SYNERGY-AI site, Portland
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
ReclutandoFase 1
- Oregon Health & Science University, Portland
Ensayos de Linfoma no Hodgkin en otras ciudades
- Houston, TX31 estudios
- New York City, NY31 estudios
- Boston, MA26 estudios
- Nashville, TN21 estudios
- Philadelphia, PA20 estudios
- Baldwin Park, CA19 estudios
- Washington, DC18 estudios
- Milwaukee, WI18 estudios
- Atlanta, GA18 estudios
- Chicago, IL18 estudios
- Columbus, OH18 estudios
- Dallas, TX17 estudios
Otros estudios en Portland
- Cáncer de pulmón de células no pequeñas46 estudios
- Cáncer (todos los tipos)34 estudios
- Cáncer de seno33 estudios
- Cáncer de próstata33 estudios
- Cáncer metastásico29 estudios
- Cáncer del colon y del recto28 estudios
- Cáncer de ovario27 estudios
- Cáncer de pulmón26 estudios
- Leucemia mielógena aguda25 estudios
- Cáncer de endometrio24 estudios
- Carcinoma de células escamosas de cabeza y cuello19 estudios
- Cáncer de páncreas19 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.